European Journal Of Clinical Investigation

EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.

EJCI 考虑从最复杂的基础分子科学到广泛分支学科的应用临床和转化研究以及循证医学的任何原创贡献。EJCI 发表与人类生物学和疾病的遗传、分子、细胞或生理基础有关的高质量研究报告，以及涉及疾病的流行、诊断、过程、治疗和预防的研究。我们主要对与人类直接相关的研究感兴趣，但也鼓励提交可靠的体外和动物研究。该期刊非常重视使用创新方法以及实验室、临床和流行病学方法和技术组合的跨学科工作和研究。几类稿件（详细描述见下文）将被考虑：社论、原创文章（还包括随机临床试验、系统评价和荟萃分析）、评论（叙述性评论）、意见文章（包括辩论、观点和评论）；以及致编辑的信。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-医学：内科领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为4.4，平均审稿速度为 约1月 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。